background image

Pancreatic Cancer Clinical Trials

Find clinical trials for pancreatic cancer. Search for pancreatic cancer clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

for
Solid Tumors, Gastric Cancer,
Location: 6 recruiting locations
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT06710132

Phase1, Phase2, Recruiting
Active & Responsive

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

for
Metastatic Pancreatic Cancer
Location: 1 recruiting location
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT04753879

Phase2, Recruiting
Active & Responsive

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

for
Solid Tumor, Adult, Colorectal Cancer,
Location: 13 recruiting locations
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT04981119

Recruiting
Active & Responsive

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

for
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer
Location: 1 recruiting location
Sponsor: Ashish Manne

Sex: All

Age: 18+

Code: NCT05624918

Phase2, Recruiting
Active & Responsive

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: 14 recruiting locations
Sponsor: Adela, Inc

Sex: All

Age: 40+

Code: NCT05366881

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

for
Triple Negative Breast Cancer (TNBC),
Location: 9 recruiting locations
Sponsor: Boundless Bio

Sex: All

Age: 18+

Code: NCT05827614

Phase1, Recruiting
Active & Responsive

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

for
High Risk Cancer, Pancreatic Cancer
Location: 1 recruiting location
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 40+

Code: NCT05013216

Phase1, Recruiting
Active & Responsive

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

for
Cyst of Pancreas, Pancreatectomy, Pancreas Neoplasm
Location: 1 recruiting location
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05720338

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: 12 recruiting locations
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT06051695

Phase1, Phase2, Recruiting
Active & Responsive

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

for
Pancreatic Cancer, Pancreatic Cyst
Location: 3 recruiting locations
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT04275557

Recruiting